Silo Pharma

SILONasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$4.678 M

$3.74 -20.02%

Close of 7 Aug 2026

Revenue

$72.1K

#3620 by revenue

Earnings

-$4.23M

Loss-making

Shares outstanding

14,166,593

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#469Bio Green Med SolutionBGMS$5.24M
#470Ernexa TherapeuticsERNA$4.91M
#471Silo PharmaSILO$4.68M
#472Jaguar HealthJAGX$4.67M
#473Galmed PharmaceuticalsGLMD$4.63M

Where these numbers come from

Share counts and financials for Silo Pharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.